Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 149678, 7 pages
http://dx.doi.org/10.1155/2010/149678
Research Article

Effect of Moderate-Intensity Exercise on Plasma C-Reactive Protein and Aortic Endothelial Function in Type 2 Diabetic Mice

1Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada V6T 1Z4
2Department of Physiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Received 3 December 2009; Revised 2 May 2010; Accepted 10 June 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Nada Sallam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Garcia, P. M. McNamara, T. Gordon, and W. B. Kannell, “Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow up study,” Diabetes, vol. 23, no. 2, pp. 105–111, 1974. View at Google Scholar · View at Scopus
  2. M. Khazaei, F. Moien-Afshari, T. J. Kieffer, and I. Laher, “Effect of exercise on augmented aortic vasoconstriction in the db/db mouse model of type-II diabetes,” Physiological Research, vol. 57, no. 6, pp. 847–856, 2008. View at Google Scholar · View at Scopus
  3. F. Moien-Afshari, S. Ghosh, S. Elmi et al., “Exercise restores coronary vascular function independent of myogenic tone or hyperglycemic status in db/db mice,” American Journal of Physiology, vol. 295, no. 4, pp. H1470–H1480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, and J. Edwin Atwood, “Exercise capacity and mortality among men referred for exercise testing,” The New England Journal of Medicine, vol. 346, no. 11, pp. 793–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Paffenbarger Jr., R. T. Hyde, A. L. Wing, I.-M. Lee, D. L. Jung, and J. B. Kampert, “The association of changes in physical-activity level and other lifestyle characteristics with mortality among men,” The New England Journal of Medicine, vol. 328, no. 8, pp. 538–545, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ghosh, M. Khazaei, F. Moien-Afshari et al., “Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice,” American Journal of Physiology, vol. 296, no. 4, pp. F700–F708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. N. G. Boulé, E. Haddad, G. P. Kenny, G. A. Wells, and R. J. Sigal, “Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials,” Journal of the American Medical Association, vol. 286, no. 10, pp. 1218–1227, 2001. View at Google Scholar · View at Scopus
  9. M. Cesari, B. W. J. H. Penninx, A. B. Newman et al., “Inflammatory markers and onset of cardiovascular events: results from the health ABC study,” Circulation, vol. 108, no. 19, pp. 2317–2322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Cesari, B. W. J. H. Penninx, A. B. Newman et al., “Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study),” American Journal of Cardiology, vol. 92, no. 5, pp. 522–528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. I. Schmidt, B. B. Duncan, A. R. Sharrett et al., “Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study,” The Lancet, vol. 353, no. 9165, pp. 1649–1652, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Verma, P. E. Szmitko, and P. M. Ridker, “C-reactive protein comes of age,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 1, pp. 29–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Visser, L. M. Bouter, G. M. McQuillan, M. H. Wener, and T. B. Harris, “Elevated C-reactive protein levels in overweight and obese adults,” Journal of the American Medical Association, vol. 282, no. 22, pp. 2131–2135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Moien-Afshari, S. Ghosh, M. Khazaei, T. J. Kieffer, R. W. Brownsey, and I. Laher, “Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice,” Diabetologia, vol. 51, no. 7, pp. 1327–1337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Korzick, M. H. Laughlin, and D. K. Bowles, “Alterations in PKC signaling underlie enhanced myogenic tone in exercise-trained porcine coronary resistance arteries,” Journal of Applied Physiology, vol. 96, no. 4, pp. 1425–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M.-D. Enderle, N. Benda, R.-M. Schmuelling, H. U. Haering, and M. Pfohl, “Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects,” Diabetes Care, vol. 21, no. 2, pp. 271–277, 1998. View at Google Scholar · View at Scopus
  18. J. Goodfellow, M. W. Ramsey, L. A. Luddington et al., “Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes,” British Medical Journal, vol. 312, no. 7033, pp. 744–745, 1996. View at Google Scholar · View at Scopus
  19. S. Makimattila, M.-L. Liu, J. Vakkilainen et al., “Impaired endothelium-dependent vasodilation in type 2 diabetes: relation to LDL size, oxidized LDL, and antioxidants,” Diabetes Care, vol. 22, no. 6, pp. 973–981, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Caballero, S. Arora, R. Saouaf et al., “Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes,” Diabetes, vol. 48, no. 9, pp. 1856–1862, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Balletshofer, K. Rittig, M. D. Enderle et al., “Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance,” Circulation, vol. 101, no. 15, pp. 1780–1784, 2000. View at Google Scholar · View at Scopus
  22. J. Calles-Escandon and M. Cipolla, “Diabetes and endothelial dysfunction: a clinical perspective,” Endocrine Reviews, vol. 22, no. 1, pp. 36–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Nyström, A. Nygren, and Å. Sjöholm, “Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction,” Clinical Science, vol. 108, no. 2, pp. 121–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. G. Schalkwijk, D. C. W. Poland, W. van Dijk et al., “Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation,” Diabetologia, vol. 42, no. 3, pp. 351–357, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Targher, L. Bertolini, G. Zoppini, L. Zenari, and G. Falezza, “Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy,” Diabetic Medicine, vol. 22, no. 8, pp. 999–1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Henareh, T. Jogestrand, and S. Agewall, “Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease,” Diabetic Medicine, vol. 22, no. 9, pp. 1212–1217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Gómez, R. Vila, P. Catalina, J. Soler, L. Badimón, and M. Sahún, “The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives,” Glycoconjugate Journal, vol. 25, no. 6, pp. 573–579, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. O. G. Pankewycz, J.-X. Guan, and J. F. Benedict, “Cytokines as mediators of autoimmune diabetes and diabetic complications,” Endocrine Reviews, vol. 16, no. 2, pp. 164–176, 1995. View at Google Scholar · View at Scopus
  29. S. Vallejo, J. Angulo, C. Peiró et al., “Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels,” Diabetologia, vol. 43, no. 1, pp. 83–90, 2000. View at Google Scholar · View at Scopus
  30. H. P. Kopp, C. W. Kopp, A. Festa et al., “Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 6, pp. 1042–1047, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth, “Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans,” Endocrinology, vol. 145, no. 5, pp. 2273–2282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Savoia and E. L. Schiffrin, “Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions,” Clinical Science, vol. 112, no. 7-8, pp. 375–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. T. de Lemos, F. Reis, S. Baptista et al., “Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats,” Medical Science Monitor, vol. 13, no. 8, pp. BR168–BR174, 2007. View at Google Scholar · View at Scopus
  34. P. C. H. Wong, M. Y. H. Chia, I. Y. Y. Tsou et al., “Effects of a 12-week exercise training programme on aerobic fitness, body composition, blood lipids and C-reactive protein in adolescents with obesity,” Annals of the Academy of Medicine Singapore, vol. 37, no. 4, pp. 286–293, 2008. View at Google Scholar · View at Scopus
  35. J. Andersson, J.-H. Jansson, G. Hellsten, T. K. Nilsson, G. Hallmans, and K. Boman, “Effects of heavy endurance physical exercise on inflammatory markers in non-athletes,” Atherosclerosis, vol. 209, no. 2, pp. 601–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Chatzinikolaou, I. G. Fatouros, V. Gourgoulis et al., “Time course of changes in performance and inflammatory responses after acute plyometric exercise,” Journal of Strength and Conditioning Research, vol. 24, no. 5, pp. 1389–1398, 2010. View at Publisher · View at Google Scholar
  37. I. Ispirlidis, I. G. Fatouros, A. Z. Jamurtas et al., “Time-course of changes in inflammatory and performance responses following a soccer game,” Clinical Journal of Sport Medicine, vol. 18, no. 5, pp. 423–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Verma, C.-H. Wang, S.-H. Li et al., “A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis,” Circulation, vol. 106, no. 8, pp. 913–919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Nagaoka, L. Kuo, Y. Ren, A. Yoshida, and T. W. Hein, “C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production,” Investigative Ophthalmology and Visual Science, vol. 49, no. 5, pp. 2053–2060, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Steffens and F. Mach, “Inflammation and atherosclerosis,” Herz, vol. 29, no. 8, pp. 741–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. B. F. de Salles, R. Simao, S. J. Fleck et al., “Effects of resistance training on cytokines,” International Journal of Sports Medicine, vol. 31, no. 7, pp. 441–450, 2010. View at Google Scholar
  42. O. J. MacEneaney, M. Harrison, D. J. O'Gorman, E. V. Pankratieva, P. L. O'Connor, and N. M. Moyna, “Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys,” European Journal of Applied Physiology, vol. 106, no. 5, pp. 721–729, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. U. Palmer-Kazen, P. Religa, and E. Wahlberg, “Exercise in patients with intermittent claudication elicits signs of inflammation and angiogenesis,” European Journal of Vascular and Endovascular Surgery, vol. 38, no. 6, pp. 689–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. B. J. Nicklas, T. You, and M. Pahor, “Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training,” Canadian Medical Association Journal, vol. 172, no. 9, pp. 1199–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. S. de Ferranti and N. Rifai, “C-reactive protein and cardiovascular disease: a review of risk prediction and interventions,” Clinica Chimica Acta, vol. 317, no. 1-2, pp. 1–15, 2002. View at Publisher · View at Google Scholar · View at Scopus